CGON
Price
$55.51
Change
+$2.93 (+5.57%)
Updated
Jan 14 closing price
Capitalization
4.48B
71 days until earnings call
Intraday BUY SELL Signals
SGMT
Price
$6.37
Change
+$0.16 (+2.58%)
Updated
Jan 14 closing price
Capitalization
207.16M
74 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CGON vs SGMT

Header iconCGON vs SGMT Comparison
Open Charts CGON vs SGMTBanner chart's image
CG Oncology
Price$55.51
Change+$2.93 (+5.57%)
Volume$1.1M
Capitalization4.48B
Sagimet Biosciences
Price$6.37
Change+$0.16 (+2.58%)
Volume$698.08K
Capitalization207.16M
CGON vs SGMT Comparison Chart in %
CGON
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CGON vs. SGMT commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and SGMT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (CGON: $55.51 vs. SGMT: $6.37)
Brand notoriety: CGON and SGMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 105% vs. SGMT: 119%
Market capitalization -- CGON: $4.48B vs. SGMT: $207.16M
CGON [@Biotechnology] is valued at $4.48B. SGMT’s [@Biotechnology] market capitalization is $207.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileSGMT’s FA Score has 1 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • SGMT’s FA Score: 1 green, 4 red.
According to our system of comparison, SGMT is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 6 TA indicator(s) are bullish while SGMT’s TA Score has 5 bullish TA indicator(s).

  • CGON’s TA Score: 6 bullish, 4 bearish.
  • SGMT’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both CGON and SGMT are a good buy in the short-term.

Price Growth

CGON (@Biotechnology) experienced а +30.77% price change this week, while SGMT (@Biotechnology) price change was +15.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

CGON is expected to report earnings on Mar 27, 2026.

SGMT is expected to report earnings on Mar 30, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($4.48B) has a higher market cap than SGMT($207M). CGON YTD gains are higher at: 33.695 vs. SGMT (7.601). SGMT has higher annual earnings (EBITDA): -64.32M vs. CGON (-179.53M). CGON has more cash in the bank: 680M vs. SGMT (117M). SGMT has less debt than CGON: SGMT (115K) vs CGON (7.24M). CGON has higher revenues than SGMT: CGON (2.17M) vs SGMT (0).
CGONSGMTCGON / SGMT
Capitalization4.48B207M2,163%
EBITDA-179.53M-64.32M279%
Gain YTD33.6957.601443%
P/E RatioN/AN/A-
Revenue2.17M0-
Total Cash680M117M581%
Total Debt7.24M115K6,297%
TECHNICAL ANALYSIS
Technical Analysis
CGONSGMT
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 17 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signal:
Gain/Loss:
SGMT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SZCRX54.400.30
+0.55%
DWS Small Cap Core R6
OIERX25.530.08
+0.31%
JPMorgan Equity Income R5
AMFEX19.260.04
+0.21%
AAMA Equity
OWACX27.89N/A
N/A
Old Westbury All Cap Core
COMZX29.38-0.49
-1.64%
DWS Digital Horizons Inst

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with RVMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+5.57%
RVMD - CGON
54%
Loosely correlated
+1.06%
NUVL - CGON
53%
Loosely correlated
+6.59%
SYRE - CGON
53%
Loosely correlated
+5.17%
IDYA - CGON
52%
Loosely correlated
+5.53%
XNCR - CGON
51%
Loosely correlated
+3.66%
More

SGMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SGMT has been loosely correlated with NGNE. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SGMT jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SGMT
1D Price
Change %
SGMT100%
+2.58%
NGNE - SGMT
40%
Loosely correlated
+10.91%
SYRE - SGMT
38%
Loosely correlated
+5.17%
FTRE - SGMT
36%
Loosely correlated
-3.45%
CGON - SGMT
36%
Loosely correlated
+5.57%
GOSS - SGMT
36%
Loosely correlated
-4.14%
More